Skip to content
中文产业新闻评分63Chinese source

中因科技ZVS101e注射液纳入CDE优先审评，用于治疗结晶样视网膜变性

中因科技ZVS101e注射液正式纳入CDE优先审评，迎来上市关键节点！

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.